OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
rAAV expressing recombinant neutralizing antibody for the botulinum neurotoxin type A prophylaxis
Artem A. Derkaev, E. I. Ryabova, I. B. Esmagambetov, et al.
Frontiers in Microbiology (2022) Vol. 13
Open Access | Times Cited: 7
Artem A. Derkaev, E. I. Ryabova, I. B. Esmagambetov, et al.
Frontiers in Microbiology (2022) Vol. 13
Open Access | Times Cited: 7
Showing 7 citing articles:
Pathogenicity and virulence of Clostridium botulinum
Alexander M. Rawson, Andrew William Dempster, Christopher M. Humphreys, et al.
Virulence (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 45
Alexander M. Rawson, Andrew William Dempster, Christopher M. Humphreys, et al.
Virulence (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 45
Single-domain antibody delivery using an mRNA platform protects against lethal doses of botulinum neurotoxin A
Eugenia A. Panova, Denis A. Kleymenov, Dmitry V. Shcheblyakov, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 21
Eugenia A. Panova, Denis A. Kleymenov, Dmitry V. Shcheblyakov, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 21
The use of adeno-associated vírus-based gene therapy to achieve long-term expression of recombinant neutralizing antibody against ricin
Kaikai Yu, Chengbiao Sun, Mingxin Dong, et al.
Toxicon (2025) Vol. 256, pp. 108289-108289
Closed Access
Kaikai Yu, Chengbiao Sun, Mingxin Dong, et al.
Toxicon (2025) Vol. 256, pp. 108289-108289
Closed Access
rAAV expressing recombinant antibody for emergency prevention and long-term prophylaxis of COVID-19
I. B. Esmagambetov, E. I. Ryabova, Artem A. Derkaev, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 9
I. B. Esmagambetov, E. I. Ryabova, Artem A. Derkaev, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 9
Broadly Reactive Nanobody Targeting the H3 Hemagglutinin of the Influenza A Virus
Dmitry V. Shcheblyakov, Daria V. Voronina, I. A. FAVORSKAYA, et al.
Acta Naturae (2024) Vol. 16, Iss. 1, pp. 101-110
Open Access | Times Cited: 2
Dmitry V. Shcheblyakov, Daria V. Voronina, I. A. FAVORSKAYA, et al.
Acta Naturae (2024) Vol. 16, Iss. 1, pp. 101-110
Open Access | Times Cited: 2
Development of technology for culturing a cell line producing a single-domain antibody fused with the Fc fragment of human IgG1
D. S. Polyansky, E. I. Ryabova, Artem A. Derkaev, et al.
Fine Chemical Technologies (2024) Vol. 19, Iss. 3, pp. 240-257
Open Access | Times Cited: 1
D. S. Polyansky, E. I. Ryabova, Artem A. Derkaev, et al.
Fine Chemical Technologies (2024) Vol. 19, Iss. 3, pp. 240-257
Open Access | Times Cited: 1
Single-domain antibody delivery using an mRNA platform protects against lethal doses of botulinum neurotoxin A
Eugenia A. Panova, Denis A. Kleymenov, Dmitry V. Shcheblyakov, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access
Eugenia A. Panova, Denis A. Kleymenov, Dmitry V. Shcheblyakov, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access
